Q&A with Bianca Horr, Clinical Project Manager, genae Germany
Q: Which factors can impact the duration of your study?
A: The duration of the study mainly depends on the type of the device you will investigate and in addition on the typical follow up of such a patient population.
For instance, when you’re dealing with an implantable device, the follow up period within the study will be longer than for a device which enters the body only for the treatment. Further impact on the study duration can be the amount of sites and the number of patients to be enrolled.
Discover our other Q&A videos:
• What is the advantage of selecting a medical device CRO for your clinical trial?
• What are the key documents or elements that a sponsor tends to forget when preparing a study?
• What pricing should we consider for investigator / patient fees?
• Are your CRA’s genae employees or do you work with consultants?
• How can you leverage information of an already conducted trial?
• How are your genae CRA’s trained?
• How do you make sure patients come back for their follow-up?
• How can you speed up enrollment?
• How does genae work with third party vendors?
• What is the difference between conducting a clinical trial in the US compared to EU?
Want to hear more about our services or how we can support your clinical trial? Feel free to contact us with any questions you may have.Contact us